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Most organisms synthesise the B6 vitamer pyridoxal 5-phosphate (PLP) via the glutamine amido-
transferase PLP synthase, a large enzyme complex of 12 Pdx1 synthase subunits with up to 12
Pdx2 glutaminase subunits attached. Deletion analysis revealed that the C-terminus has four dis-
tinct functionalities: assembly of the Pdx1 monomers, binding of the pentose substrate (ribose
5-phosphate), formation of the reaction intermediate I320, and ﬁnally PLP synthesis. Deletions of dis-
tinct C-terminal regions distinguish between these individual functions. PLP formation is the only
function that is conferred to the enzyme by the C-terminus acting in trans, explaining the cooper-
ative nature of the complex.
Structured summary:
MINT-7994448: PfPdx1 (uniprotkb:C6KT50) and PfPdx1 (uniprotkb:C6KT50) bind (MI:0407) by molecular
sieving (MI:0071)
MINT-7994425, MINT-7994413, MINT-7994435: PfPdx1 (uniprotkb:C6KT50) and PfPdx1 (uni-
protkb:C6KT50) bind (MI:0407) by cosedimentation in solution (MI:0028).
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Malaria is caused by parasites of the genus Plasmodium. It is a
disease that imposes a tremendous burden on global health putt-
ing over 2 billion people at risk and afﬂicting over 500 million peo-
ple worldwide [1]. As current therapeutics are increasingly
ineffective [2] and a clinically available vaccine is not in sight, there
is an urgent need to identify and characterize new targets enabling
novel chemotherapeutic strategies. The biosynthesis of vitamins is
of particular interest in this respect, since the absence of these
pathways in humans implies that their inhibition exclusively af-
fects the metabolism of the parasite and not that of the humanchemical Societies. Published by E
; PfPdx2, Pdx2 of Plasmodium
l b-D-1-thioglacatopyranoside;
ate
: +49 6221 544749.
: +49 6221 564643.
(I. Tews), barbara.kappes@ur-
tion Biology, Department ofhost. Plasmodium is able to synthesize certain vitamins de novo,
either completely or in parts [3,4]. Among these is vitamin B6 [5,6].
The term vitamin B6 collectively refers to the vitamers pyri-
doxal, pyridoxine, pyridoxamine and their related phosphate es-
ters. The metabolically active forms are pyridoxal 5-phosphate
(PLP) und pyridoxamine 5-phosphate (PMP). PLP has been de-
scribed as nature’s most versatile cofactor and is involved in more
than 100 enzymatic reactions [7,8]. In the malaria parasite, PLP is
synthesized through the so-called deoxyxylose 5-phosphate inde-
pendent pathway, in which the proteins Pdx1 and Pdx2 form a het-
eromeric class I glutamine amidotransferase [5,6]. The fully
assembled PLP synthase complex consists of two interacting
Pdx1 hexamers plus up to 12 Pdx2 molecules attached to them
[9,23]. The glutaminase subunit Pdx2 generates ammonia –
through the hydrolysis of glutamine – the source of the required
ring nitrogen in the synthase reaction catalyzed by Pdx1 [11,12].
Ribose 5-phosphate (R5P) and glyceraldehyde 3-phosphate (G3P)
are substrates of the synthase reaction catalysed by Pdx1 along
with ammonia provided by Pdx2 [13].
The activity of the PLP synthase system is highly regulated
[7,14–19]. Cooperativity between Pdx1 subunits is induced uponlsevier B.V. All rights reserved.
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allosteric effector of Pdx1 when its substrate glutamine is bound
and then further enhances the afﬁnity of Pdx1 for R5P [18]. Com-
bined cross-linking and mass spectrometry data suggest an inter-
subunit cross-talk by interaction of the C-terminus of one
subunit with a region immediately downstream of helix a800 in
the C-terminus of an adjoining monomer [18].
Here, we have investigated Plasmodium falciparum PLP synthase
and report that helix a800 is a prerequisite for hexamer assembly,
and consequently for dodecamer formation. C-terminal deletion
studies demonstrate that imine formation between R5P and K83
and subsequent conversion to the chromophoric I320 intermediate
only requires six amino acid residues additional to helix a800. How-
ever, full PLP synthetic activity then requires the native C-terminus.
Hexamer/dodecamer formation is a prerequisite for covalent R5P-
binding and accordingly for PLP synthase activity, however the glu-
taminasedoes not require anoligomeric Pdx1 complex for activation.
2. Materials and methods
2.1. Reagents
Antibiotics were purchased from AppliChem (Darmstadt, FRG),
imidazole, 2-amino-2-(hydroxymethyl)-1,3-propanediol (Tris),
NaCl, NH4Cl, EDTA, Luria-Broth medium (LB), b-mercaptoethanol
from Carl Roth (Karlsruhe, FRG), isopropyl b-D-1-thiogalactopyra-
noside (IPTG) was from PeqLab (Erlangen, FRG), L-glutamine, DL-
G3P and R5P from Sigma–Aldrich (Taufkirchen, FRG). Restriction
enzymes and DNA-polymerases were from New England Bioloabs
(NEB, Schwalbach, FRG).
2.2. Molecular biology
Cloning of Pdx1 of Plasmodium falciparum (PfPdx1) into
pET21a(+) has been described previously [5]. PfPdx1 and the C-ter-
minally truncated versions PfPdx1D270–301, PfPdx1D273–301,
PfPdx1D279–301 and PfPdx1D287–301 were generated by standard
PCR and site mutagenesis using PfPdx1 as template and oligonu-
cleotide primers as given in Supplement. All fragments were
cloned via NdeI/XhoI restriction sites into pET28a(+) (Novagen,
Merck, Nottingham, UK) generating N-terminally 6 His-tagged
fusion proteins. The generation of additional deletion variants is
described in Supplement.
2.3. Protein expression and puriﬁcation
Plasmidswere transformed into E. coli BL21-CodonPlus(DE3)-RIL
cells (Stratagene, Amsterdam, NL) and expressed at 37 C in LBmed-
ium containing 35 lg/ml chloramphenicol and 30 lg/ml kanamy-
cin. The cells were induced at an OD600 of 0.5 with 0.1 mM IPTG.
The bacteria were harvested after 3 h, washed with 150 mM NaCl
and stored at 80 C. For puriﬁcation, the cell pellets were thawed
and resuspended in lysis buffer (50 mM Tris–HCl pH 8.0, 300 mM
NaCl, 20 mM imidazole, 10 mM b-mercaptoethanol) and disrupted
by soniﬁcation. The lysate was cleared by centrifugation (30 min,
20 000g, 4 C) and applied to Ni-NTA agarose (QIAgen, Hilden,
FRG). Afterwashingwith 40 mM imidazole the proteinswere eluted
with200 mMimidazole in lysis buffer. Except forPfPdx1D279–301, the
puriﬁed variants were concentrated using Amicon centrifugal ﬁl-
ter devices with a molecular weight cut-off of 30 kDa (Millipore
Corp., Billerica, USA) and applied to a Superdex 200 10/300 GL
column (GE Healthcare, Freiburg, FRG) equilibrated with assay
buffer (20 mM Tris–HCl pH 8.0, 10 mM NaCl, 0.5 mM EDTA).
PfPdx1D279–301 interacted with the Superdex matrix, therefore
fractions containing the variant were pooled after the Ni-NTA
puriﬁcation and dialysed over night against assay buffer.2.4. Enzymatic assays
All variants were tested for PLP synthase activity as described in
Refs. [5,19]. Formation of PLP was assayed using a Jasco V-550
spectrophotometer (Jasco, Groß-Umstadt, FRG) at a wavelength
of 414 nm at 37 C for 30 min. Formation of the I320 chromophoric
intermediate was monitored at 315 nm [17]. 20 lM puriﬁed
PfPdx1 or variants and 20 lM Pdx2 of Plasmodium falciparum
(PfPdx2) were incubated in assay buffer in the presence of 1 mM
R5P, 1 mM G3P and 10 mM L-glutamine. In the absence of PfPdx2,
10 mM NH4Cl was used as nitrogen source. G3P was not added for
the analysis of I320-formation.
Glutaminaseactivitywasdeterminedasdescribedpreviously [5].
Brieﬂy, 5 lM of PfPdx1 or variants and 5 lM of PfPdx2 were incu-
bated for 15 min at 30 Cwith10 mML-glutamine, 0.5 mM3-acetyl-
pyridine adenine dinucleotide (APAD) and 10 U glutamate
dehydrogenase. Reduction of APAD to APADH was monitored at
363 nm.
2.5. Static light scattering
To determine the absolute molecular weight without the use
of internal standards, a gel ﬁltration setup using a Superdex 200
10/300 GL size exclusion chromatography column (GE Healthcare,
Freiburg, FRG) in line with static light scattering was used. The buf-
fer used was 20 mM Tris–HCl pH 8.0, 100 mM NaCl. For in-line
detection, a Mini Dawn light scattering instrument (Wyatt Tech-
nology, Dernbach, FRG) and a refractory index detector (WGE
Dr. Bures, Dallgow, FRG) were used. Data were evaluated using
the AstraV software (Wyatt Technology, Dernbach, FRG).
2.6. Analytical ultracentrifugation
The oligomeric states of PfPdx1 and all deletion variants were
analysed by analytical ultracentrifugation (AUC). The sedimenta-
tion velocity was determined using a Beckman Optima XL-A ultra-
centrifuge (Beckman Coulter, USA). Runs were performed at 20 C,
35 000 rpm or 42 000 rpm, k = 280 nm, with a protein concentra-
tion of 65 lM in a buffer comprised of 20 mM Tris–HCl pH 8.0
and 100 mM NaCl. Buffer density, viscosities and protein partial
speciﬁc volumes were calculated with the SEDNTERP program ver-
sion 1.09 (http://www.rasmb.bbri.org, [20]). For analysis of the
AUC data the program SEDFIT version 11.9b [21] was used. Calcu-
lations of sedimentation coefﬁcients from the crystal structure
coordinates were performed with the software HYDROPRO [22].
2.7. Mass spectrometry
Protein samples were puriﬁed using reversed phase lC4 micro-
pipette tips (ZipTips, Millipore, Billerica, MA, USA) according to the
manufacturers’ protocol. NanoESI-MS experiments were carried
out on a QTOF2 mass spectrometer (Waters, Micromass, Manches-
ter, UK). Samples were sprayed from in-house produced gold
coated spray needles. Static electrospray was established by apply-
ing a capillary voltage of 1000 V. Data acquired were analyzed by
MassLynx 4.1.3. Results
The C-terminal region of Pdx1 is responsible for intersubunit
cross-talk and confers cooperativity to the enzyme [18]. The full
C-terminus of Pdx1 is not resolved in prokaryotic 3D structures
[9,10,23] and in these structures helix a800 is the most C-terminal
secondary structure element in the core of Pdx1 (Fig. 1A). However,
a substantial portion of the C-terminus has been resolved with the
AB
Fig. 1. Deletion analysis of Pdx1 of Plasmodium falciparam. (A) Shown is the structure of Saccharomyces cerevisiae Pdx1 (3FEM); two stereo views of adjacent subunits of one
hexamer are presented. Large parts of the 3D structure have been omitted for clarity. The C-terminal regions of previously determined structures from Thermotoga maritima
(TmPdx1, yellow, 2ISS), Methanocaldococcus jannaschii (MjPdx1, magenta, 2YZR) and Bacillus subtilis (BsPdx1, blue, 2NV2) are also shown. Pi stands for inorganic phosphate
and indicates the binding site for the substrate pentose phosphate. (B) The alignment displays the relevant sequences and the secondary structure assignment. In the
alignment, amino acids present in the 3D structure are given in capital and boxed. The sequence of PfPdx1 is given with a secondary structure prediction using Jpred 3 [26].
The table lists enzymatic activities and oligomeric state for the referenced PfPdx1 deletion variants. n.d.: not determined.
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cerevisiae [24]. In the yeast structure, helix a800 is followed by arandom coil region leading into helix aC [24]. Remarkably, the
partly resolved random coil regions of the bacterial structures
Table 1
Biochemical characterization of PfPdx1 and its C-terminal truncation variants using NH4Cl as ammonium donor.
Protein R5P-bindinga I320-speciﬁc activity PLP-speciﬁc activity Oligomeric stateb
nmol min1 mg1 % pmol min1 mg1 %
PfPdx1 + 1.22 ± 0.04 100 695 ± 71 100 Dodecamer
PfPdx1D270–301  n.d. 0 n.d. 0 Mainly monomer
PfPdx1D273–301  n.d. 0 n.d. 0 Dodecamer
PfPdx1D279–301 + 1.3 ± 0.4 107 351 ± 77 51 Dodecamer
PfPdx1D287–301 + 1.9 ± 0.2 155 –c –c Dodecamer
Assays were performed with 20 lM protein, 1 mM R5P, 1 mM G3P, 10 mM NH4Cl in 20 mM Tris–HCl pH 8.0, 10 mM NaCl, 0.5 mM EDTA. The activity of
PfPdx1 was set as 100 %. Experimental results are means of at least three independent measurements. n.d.: none detected.
a Compare Table 4.
b Compare Table 3.
c Protein precipitated upon addition of G3P.
4172 B. Derrer et al. / FEBS Letters 584 (2010) 4169–4174and the yeast structure superpose well, suggesting relevance of the
observed conformation in this region (Fig. 1A).
Secondary structure predictions for the C-terminus of PfPdx1
conﬁrm the positioning of helix a800, however, the predicted C-ter-
minal helix aC is shifted and extended compared to that of Saccha-
romyces Pdx1. Based on this analysis, we designed the following
C-terminal deletion variants: PfPdx1D270–301, truncating the pro-
tein at the last turn of helix a800; PfPdx1D273–301, truncating the
protein immediately after helix a800; PfPdx1D279–301, truncating
the protein between helices a800 and aC; and ﬁnally PfPdx1D287–
301, truncating the protein after the resolved part of helix aC in S.
cerevisiae Pdx1 but before the predicted helix aC of P. falciparum
(Fig. 1B; additional variants indicated in the ﬁgure are presented
in Supplement). After expression and puriﬁcation, the variants
were characterized with respect to their oligomeric state and their
abilities to bind R5P, to form the chromophoric reaction intermedi-
ate I320 [13,17] and to synthesise PLP [5]. Furthermore, the gluta-
minase activity of the Pdx1/Pdx2 complex was determined [5].
The oligomerisation behaviour of Pdx1 was altered in the
shortest variant, PfPdx1D270–301, as determined by analytical ultra-
centrifugation (Tables 1 and 3, Fig. 2A). This behaviour was inde-
pendently conﬁrmed by size exclusion chromatography coupled
with static light scattering (Fig. 2B). The dominant species was
the monomer with a sedimentation coefﬁcient of 3.0 ± 0.1 S mak-
ing up roughly two thirds (68%) of the total protein. Species with
sedimentation coefﬁcients of 4.8 ± 0.5 S and 6.9 ± 1.1 S correspond-
ing roughly to dimeric and tetrameric forms were also present. TheFig. 2. Oligomeric nature of PfPdx1D270–301 analyzed in solution (A) the main peak
sedimentation coefﬁcient s = 3.0 S, which corresponds to a monomeric species with a m
4.8 S and 6.9 S, respectively. These represent higher oligomeric forms that appear to be in
mass determination without use of internal standards, size exclusion chromatography in
mass of the observed peak was 35 kDa ± 2%.analytical ultracentrifugation data displayed broad peaks for the
oligomeric species suggesting a fast equilibrium between several
states (Fig. 2A). Interestingly, PfPdx1D270–301 was able to fully acti-
vate the glutaminase Pdx2, suggesting that the monomeric species
retained this propensity (Table 2). This also suggests that this trun-
cation variant possesses an intact Pdx1–Pdx2 interface.
PfPdx1D270–301 proved to be catalytically inactive for I320 and
PLP formation either alone or in complex with PfPdx2 (Tables 1
and 2). This prompted us to investigate whether this variant is able
to bind R5P. PfPdx1D270–301 was incubated with R5P and the
molecular mass was determined by ESI-MS. When wild-type
PfPdx1 is incubated with R5P, the determined molecular mass in
ESI-MS changes by 212 Da, reﬂecting the formation of a covalent
Schiff base between R5P and the catalytic lysine 83 (Table 4)
[10,14,17,18]. However, the molecular mass of PfPdx1D270–301 re-
mained unaltered upon incubation with R5P, indicating that this
variant is incapable of forming the covalent imine intermediate
with its pentose substrate (Tables 1 and 4).
In PfPdx1D270–301, PfPdx1 is truncated within helix a800 which is
at the oligomerisation interface. Hence the deletion mutant
PfPdx1D273–301 was examined in which the truncation occurs just
after helix a800 and this protein was found to form dodecamers
(Tables 1 and 3). The three additional amino acids in PfPdx1D273–301
are a conserved serine that makes a hydrophilic contact with a
backbone atom of the preceding helical turn followed by two sol-
vent exposed and variable residues. A mutant in which the serine
was replaced by an alanine (PfPdx1S270AD273–301 variant; seeobserved in sedimentation velocity analytical ultracentrifugation is ﬁtted to a
olecular mass of 29 kDa. The sedimentation coefﬁcients of the minor peaks were at
a rapid equilibrium, as suggested by the shallow shape of the peaks. (B) For absolute
line with RI-detection and static light scattering was performed. The ﬁtted molecular
Table 3
Analysis of Pdx1 and the C-terminal truncation variants by analytical ultracentrifu-
gation (velocity sedimentation).
Protein sexp (S)a Mexp (kDa)b Mcal (kDa)c
PfPdx1 14.0 363 420
PfPdx1D270–301d Peak 1: 3.0 ± 0.1
Peak 2: 4.8 ± 0.5
Peak 3: 6.9 ± 1.1
29 ± 3
60 ± 12
110 ± 26
31
–
–
PfPdx1D273–301 12.9 324 380
PfPdx1D279–301 13.0 330 387
PfPdx1D287–301 13.8 354 400
a The c(S) distribution of sedimentation coefﬁcients was determined with SEDFIT
[21] and corrected to standard conditions (20 C, H2O). Calculated s values using
HYDROPRO and 3.1 Å bead size [22] are 2.7 S for the monomeric and 15.4 S for the
dodecameric species.
b Molecular mass derived from molar mass distributions c(M) calculated by
SEDFIT. For all dodecameric variants the frictional ratio was ﬁxed to 1.25 (average of
all experiments).
c Molecular mass calculated from the amino acid composition.
d Three different species were detected. The monomeric form ﬁtted to 3.0 ± 0.1 S
and comprised about two thirds of the total protein. The standard deviation is given
on the basis of three independent experiments. Higher oligomeric forms are
probably in fast equilibrium giving rise to larger errors as discussed in the text (no
theoretical s and M values calculated).
Table 4
Molecular mass of PfPdx1 and the C-terminal truncation variants in the
absence or presence of ribose 5-phosphate as determined by ESI-MS.
Protein R5P (Da) +R5P (Da)
PfPdx1 35320.7 35532.6
PfPdx1D270–301 31506.8 31506.8
PfPdx1D273–301 31722.6 31722.6
Table 2
Biochemical characterization of PfPdx1 and its C-terminal truncation variants in presence of PfPdx2.
Protein + PfPdx2 I320-speciﬁc activity PLP-speciﬁc activity Glutaminase-speciﬁc activity
nmol min1 mg1 % pmol min1 mg1 % nmol min1 mg1 %
PfPdx1 2.76 ± 0.2 100 779 ± 130 100 193.90 ± 14 100
PfPdx1D270–301 n.d 0 n.d. 0 190.60 ± 3 99
PfPdx1D273–301 n.d 0 n.d. 0 202.77 ± 16 105
PfPdx1D279–301 4.62 ± 0.4 167 250 ± 32 32 271.62 ± 8 140
PfPdx1D287–301 2.25 ± 0.1 83 –a –a 182.76 ± 9 94
Assays were performed with 20 lM protein, 1 mM R5P, 1 mM G3P, 10 mM L-glutamine in 20 mM Tris–HCl pH 8.0, 10 mM NaCl, 0.5 mM EDTA. The activity of PfPdx1/PfPdx2
was set as 100%. Experimental results are means of at least three independent measurements. n.d. – none detected.
a – Protein precipitated on addition of G3P.
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the length of the helical segment is crucial for the integrity of the
oligomerisation interface.
The PfPdx1D273–301 variant was unable to produce the chromo-
phoric reaction intermediate I320 and, consequently, has no PLP
synthetic activity (Tables 1 and 2). Similarly, the BsPdx1D273–294
variant, roughly equivalent to PfPdx1D273–301 but containing two
additional amino acids at the C-terminus, was severely impaired
in the formation of the chromophore (0.5% of wild-type activity)
and displayed no detectable PLP synthase activity [18]. Using ESI-
MS, we could show that PfPdx1D273–301 was unable to covalently
bind the pentose substrate (Tables 1 and 4). However,
PfPdx1D273–301 was able to fully activate PfPdx2 similarly to the
wild-type protein (Table 2).
Inclusion of additional six amino acid residues in PfPdx1D279–301
elicits chromophore-speciﬁc activity. This variant is dodecameric
in nature (Tables 1 and 3) and shows chromophore-speciﬁc activity
similar to the wild-type protein, whereas PLP-speciﬁc activity was
halved (Table 1). The six additional amino acids, of which glycine274 and methionine 277 are conserved among Pdx1 orthologs,
are thus required for imine formation with R5P and the formation
of the chromophoric intermediate. I320-speciﬁc activity increased
above that of wild-type in the Pdx2-dependent assay (167% versus
100%; Table 2), while PLP-speciﬁc activity was further reduced
(32%; Table 2). Thus, Pdx2 in its glutamine bound form has an
inﬂuence on chromophore formation, exerting an allosteric effect
[18], even when only the truncated form is considered.
PfPdx1D287–301 contains the segment equivalent to the resolved
part of helix aC of the S. cerivisiae Pdx1. This variant forms dodeca-
mers and exhibits chromophore-speciﬁc activity (Tables 1–3). Un-
like PfPdx1D279–301, the I320-speciﬁc activity of PfPdx1D287–301 was
greater than that of wild-type in the absence of Pdx2 (155% versus
100%), but slightly decreased in the presence of Pdx2 (83% versus
100%) (Tables 1 and 2). Further, no PLP-speciﬁc activity could be
determined for PfPdx1D287–301, since addition of G3P resulted in
an instantaneous precipitation of the protein. Indeed, we have
tested two further deletion variants and observed the same behav-
iour and similar stability problems (PfPdx1D293–301 and
PfPdx1D295–301, see Supplement). The very C-terminus with the
predicted C-terminal helix likely is an independent functional do-
main allowing Pdx1 to accommodate conformational changes that
occur upon or as a consequence of G3P binding. If the integrity of
this domain is disturbed, G3P integration into the forming PLP mol-
ecule is impaired. Thus, only the native C-terminus ensures opti-
mal PLP biosynthesis.
4. Discussion
The C-terminus of Pdx1, which has evaded structural determi-
nation, is essential for catalytic activity of the protein [18]. In the
current study, we performed a deletion analysis and assigned spe-
ciﬁc functions to deﬁned regions of the C-terminus. Variants were
characterized with respect to (i) their ability to form the hexamer/
dodecamer state of wild-type protein, (ii) their enzymatic proper-
ties, i.e., substrate binding, I320-formation and PLP synthesis, and
(iii) their ability to activate Pdx2, the glutaminase partner.
The PfPdx1D270–301 variant with truncated helix a800 was the
only variant that had defective oligomerization behaviour. This
protein adopted several oligomeric states with the monomer being
the predominant species (Fig. 2). The other deletion variants tested
here showed dodecameric organization. Thus, integrity of helix a800
is essential to stabilize the oligomer, as can be proposed on the ba-
sis of crystallographic analyses [9,10,23]. Exchanges of conserved
amino acid residues in the loop preceding helix a3, which likewise
are at the interface between protamers, also affected the oligomer-
isation behaviour of Pdx1 [25].
Interestingly, the PfPdx1D270–301 variant was able to fully acti-
vate the glutaminase PfPdx2 (Table 2). It is possible that this activ-
ity is due to presence of transient hexamers. However, glutaminase
activation is identical to native PfPdx1/PfPdx2 complexes and on
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and activate the Pdx2 glutaminase. Importantly, this is in contrast
to the earlier ﬁnding that the monomeric Pdx1 variant with ex-
changes of conserved amino acid residues in the loop preceding
helix a3 was unable to activate the glutaminase partner Pdx2 [25].
Neither PfPdx1D270–301 nor PfPdx1D273–301 was capable of cova-
lently binding the substrate R5P. This suggests that a Pdx1 dode-
camer is required for binding of the pentose substrate and that
the protein must extend over the ‘‘minimal” core as represented
by the PfPdx1D273–301 variant. The PfPdx1D279–301 variant then
binds R5P and also forms the I320 intermediate and PLP. Full PLP
synthase activity, however, requires the native C-terminus from
amino acid 279 onward. Thus, within the C-terminal segment
investigated here, R5P-binding and I320-formation are assigned to
amino acids 273–278.
The C-terminal region from residue 273 on is in close proximity
to helix a80 and the loop between b6 and a6 of the (ba)8-barrel
(Fig. 1A) both of which have been implied in phosphate binding
of the substrate R5P [10]. It is likely that the C-terminal segment
helps organising the whole structural region and in consequence
substrate binding, because of two reasons: the observed close
proximity and the observation that the C-terminal segment super-
poses well in all structures, where it was resolved (Fig. 1A).
The PfPdx1D279–301 variant is competent for PLP formation,
however, at a reduced level (Tables 1 and 2). It is therefore quite
likely that the C-terminus beyond Cys278 including helix aC is an
independent domain required for optimal PLP production. Inter-
estingly, helix aC is in close proximity to helix a20 of a neighbour-
ing subunit [24]. This likely explains the observed cooperativity in
the oligomeric enzyme [18]. Raschle et al. proposed that the C-ter-
minus may act as a lid to close the active site, and they proposed
this function is dependent on presence of R5P [18]. The structural
and mutational analysis presented here now suggests that the
ﬁrst part of the C-terminus acts in cis, organising phosphate bind-
ing of the pentose substrate, while, by analogy to the S. cerevisiae
structure, the very C-terminus from helix aC onward acts in trans,
organising the a20 region, likewise implied in pentose binding.
The truncation variant PfPdx1D279–301 cannot interact with a
neighbouring subunit in the proposed way and consequently lacks
full PLP synthase activity. In contrast, the PfPdx1D287–301 variant
would be able to interact in trans with the a20 region, but because
it precipitated upon addition of G3P – as do the variants, which
were truncated C-terminally of PfPdx1D287–301 – formation of
PLP could not be determined making it impossible to further ana-
lyze this region. We conclude that the region C-terminal to helix
aC further enhances PLP formation, presumably by mediating
G3P binding and/or steps subsequent to G3P incorporation.
Together, the data argue for an important structural role of the
C-terminus in catalysis, which explains the rather limited conser-
vation in this region and probably the lack of consensus catalytic
residues.
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